Background The CRASH-2 trial showed that early administration of tranexamic acid (TXA) safely reduces mortality in bleeding in trauma patients. Based on data from the CRASH-2 trial, global mortality ...

Researchers from Osaka University use machine learning to identify patients more likely to survive traumatic injury if treated with tranexamic acid Osaka, Japan – Worldwide, approximately 4.5 million ...

Use of tranexamic acid in traumatic injury emergencies reduces mortality, with no significant increase in problematic vascular occlusive events. This systematic review and bias-adjusted meta-analysis ...

A new study shows that a TXA autoinjector delivers lifesaving treatment for severe bleeding as effectively as traditional IV methods — but in under five minutes and without the need for medical ...

The Vallejo Fire Department announced on Monday that its firefighter paramedics are the first medical professionals in Solano County to administer Tranexamic Acid, a groundbreaking medication used to ...

Prehospital administration of tranexamic acid in patients with severe trauma who were at risk for coagulopathy might increase the likelihood of a favorable functional outcome in advanced trauma ...

JERUSALEM, Nov. 19, 2025 /PRNewswire/ -- Rafa Laboratories, a global leader in Chemical, Biological, Radiological, and Nuclear hazards medical countermeasures and Biodefense, today announced it has ...

A British researcher turns to claymation to promote a life-saving drug. Nov. 17, 2011— -- Ian Roberts is an epidemiologist, but he's venturing into territory usually reserved for breakfast cereal ...

Researchers have used machine learning to identify subgroups of trauma patients who are more likely to survive their injuries if treated with tranexamic acid. This treatment controls bleeding and ...